March 19, 2012 — The risk classification for nucleic acid–based tests is being downgraded from class 3 (high risk) to class 2 (moderate risk) by the US Food and Drug Administration (FDA), which will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback